The FDA has given C.R. Bard premarket approval for its LifeStream covered iliac stent, a device intended for treating patients with peripheral artery disease. The approval is for the use of the device in treating atherosclerotic lesions in external and common iliac arteries with lesion lengths of up to 100 mm and diameters ranging from 4.5 mm to 12 mm.
C.R. Bard's covered iliac stent gets premarket approval from FDA
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.